Trial intelligence / Profile preview

Botox for chronic scrotal pain

NCT02249234Phase 2Completed

Sponsor
Mount Sinai Hospital
Start
Aug 2014
Primary completion
Oct 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of botulinum toxin type A, sponsored by Mount Sinai Hospital. Started Aug 2014; status: completed.

02

Drugs

botulinum toxin type A

Beyond the preview

Go deeper on NCT02249234.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02249234.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call